Navigation Links
Biocon to colloborate for development of Oral peptide drugs for heart diseases.

The Indian Biotech Company, Biocon to colloborate with Nobex Corporation of United States to develop a new oral peptide drug for cardiovascular diseases. The spokesperson of Biocon informed that the company has gone into global research collaboration // on Tuesday for development of peptide based product for treatment of cardiovasculoar diseases. The Biocon press release said, “The collaboration combines the peptide production capabilities of Biocon with the proprietary oral peptide deliver technology of Nobex. Biocon and Nobex plan to advance the oral human brain type natriuretic peptide (hBNP) program towards an Investigational New drug filing with the US food and Drug Administration in 2007 and clinical trials beginning later that year.

“Administration of hBNP by continuous infusion was approved by the FDA in August 200 for the treatment of acute congestive heart failure in the hospital care setting. The intent of an oral hBNP would be to have a product available for chronic use, rather than only for acute use for a number of potential indications, including early stage heart failure patients.’ It said.

“By co-developing a therapeutic product such a oral hBNP of substantial clinical and market value in treating heart failure and other potential cardiovascular indications, we are taking another step towards our innovative product development strategy,” the release quoted Ms Kiran Mazumdar-Shaw, chairman and managing director of Biocon, as sayin.
'"/>




Page: 1

Related medicine news :

1. Biocon To Raise Its Investment In Scotland
2. Biocon To Shift Focus On Innovation To Accelerate Growth
3. Kalam Dedicates New Cancer Drug Developed By Biocon
4. Bayer to Market Biocon Insulin in China
5. Biocon Launches Anti-Cancer Drug
6. Biocon to Launch Anti-arthritis Drug
7. Biocon Unveils Renal Therapies for Kidney Disorders
8. Biocon Net Profit Up by 15 Percent for Fiscal Year
9. Cancer drugs in development nearly doubled since 1995
10. Role of zinc in development
11. Particulate matter affects lung development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... Pets bring laughter, joy and love ... pet owners celebrate National Pet Week, which falls on the first full week of ... to cherish the human-animal bond and recognize responsible pet ownership. Pet owners can live ...
(Date:5/2/2016)... ... May 02, 2016 , ... “Engineering Bubbles,” an oil painting submitted by Canadian ... Forum held recently at the Annual Meeting in Los Angeles. The first annual art ... members and Annual Meeting attendees. , “Through art I hope to educate people ...
(Date:5/2/2016)... ... May 02, 2016 , ... Over $60 Billion is spent ... pet gear and toys, leading product review site for Toys, Tots, Pets & More ... at their Spring Showcase at the Metropolitan Pavilion in New York City. , ...
(Date:5/2/2016)... NV (PRWEB) , ... May 02, 2016 , ... ... Pharmacy Times, has announced a new Specialty Pharmacy Patient Satisfaction Award that will ... based on the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction ...
(Date:5/2/2016)... ... May 02, 2016 , ... According to an American Psychological ... girls are sexually abused before the age of 18. Of those who survive, many ... story and others. , In her new book, Lyah! Lyah! Pants on Fyah!, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- Treato , the single largest ... that it has been named a Cool Vendor by ... Sciences, 2016, Stephen Davies , Michael ... life-science- oriented analytics, algorithms and smart machine technology in ... medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
Breaking Medicine Technology: